Nuvation Bio Inc.
Nuvation Bio Inc. scores highest on Earnings (70) and lowest on Price (11). Its PosiPenta is 42.05 out of 100, around the middle of similar companies.
On the Penta Grid this week, Nuvation Bio Inc. is Grid #467 of 837 in the Healthcare sector in United States, and Grid #2,689 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Nuvation Bio Inc. | 42.05 | 11 | 70 | 43 | 31 | 55 |
| Novavax, Inc. | 56.50 | 0 | 56 | 85 | 97 | 44 |
| Stoke Therapeutics, Inc. | 39.82 | 15 | 21 | 54 | 59 | 50 |
| Generate Biomedicines, Inc. | 40.10 | 19 | 27 | 44 | 47 | 63 |
| Sonida Senior Living, Inc. | 49.16 | 29 | 40 | 77 | 37 | 62 |
| Hemab Therapeutics Holdings, Inc. | 49.46 | 21 | 33 | 51 | 81 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -10.11 |
| P/B ratio | 6.15 |
EEarnings
| Trailing EPS | ₹-41.67 |
| Forward EPS | ₹-1.42 |
NNitro
| Price | 421.48 |
| 52-week high | 923.47 |
| 52-week low | 318.24 |
| Fall from 52-week high | 54.4% |
TTorque
| Return on equity (ROE) | -47.81% |
| Debt-to-equity | 1.64 |
AAnchor
| Beta (price swings) | 1.62 |
| Market cap | ₹14,799 Cr |
| Insider holding | 17.19% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nuvation Bio Inc.'s PosiPenta score?
Nuvation Bio Inc.'s PosiPenta is 42.05 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Nuvation Bio Inc. stand on the Penta Grid?
On the Penta Grid this week, Nuvation Bio Inc. is Grid #467 of 837 in the Healthcare sector in United States, and Grid #2,689 of 4,000 in United States.
Which PosiPenta pillar is strongest for Nuvation Bio Inc.?
Earnings (growth), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Nuvation Bio Inc.?
Price (valuation), with a score of 11 out of 100: much weaker than most similar companies.
Has Nuvation Bio Inc.'s PosiPenta changed since last week?
Yes, it rose 3.57 points, from 38.48 to 42.05.
PositoAI is for research and education only and is not investment advice.